Institutional investors purchased a net $13.7 million shares of OPK during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 19.45% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ORCHARD HILL CAPITAL MANAGEMENT ... Bought 6.9 Million shares of OPKO Health Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 4.5 Million shares of OPKO Health Inc
LBMC INVESTMENT ADVISORS LLC Bought 1.6 Million shares of OPKO Health Inc